Colgate-Palmolive (CL) Tops Q4 EPS by 1c, Comments on Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Colgate-Palmolive Company (CL) PT Lowered to $57 at Macquarie
January 29, 2019 6:52 AM ESTMacquarie analyst Caroline Levy lowered the price target on Colgate-Palmolive Company (NYSE: CL) to $57.00 (from $60.00) while maintaining a Neutral rating. Macquarie cut 2019 EPS estimates to $2.84, 2020 to $3.00 and 2021 to $3.20 (from $2.95, $3.13 and $3.33), for lower ebit margin outlook.
Levy remains cautious on the outlook for the... More
